EURALex is now part of the Regulatory Affairs Journals

Maximise the impact of your regulatory affairs information

In light of the current financial climate, it has never been more important for legal and regulatory affairs professionals to obtain accurate, expert regulatory news and analysis for their industry.

With this in mind, EURALex has been incorporated into the Regulatory Affairs Journals, RAJ Pharma and RAJ Devices, providing readers with the full complement of worldwide regulatory affairs information and analysis of how it will affect them.

For over 18 years, RAJ has been the leading global information service for those working in legal and regulatory affairs for the pharmaceutical, biotech, medical devices and diagnostics industries. Drawing upon a pool of over 30 reporters and industry correspondents worldwide, RAJ offers readers in-depth news, features and analysis often not available elsewhere.

Follow the relevant link for more information on either RAJ Pharma or RAJ Devices, or to access headlines from the latest issue.

Information for current subscribers: download the letter released to subscribers with the December issue here or email regulatory@informa.com with your enquiry.